• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外循环手术中头孢呋辛的血药浓度。

Blood concentrations of cefuroxime in cardiopulmonary bypass surgery.

机构信息

Department of Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen, The Netherlands,

出版信息

Int J Clin Pharm. 2013 Oct;35(5):798-804. doi: 10.1007/s11096-013-9810-z. Epub 2013 Jun 21.

DOI:10.1007/s11096-013-9810-z
PMID:23794078
Abstract

OBJECTIVES

Patients with coronary artery bypass graft (CABG) surgery are at risk for severe postoperative infections. Prophylactic cefuroxime may help to reduce this risk, however sufficient concentrations, i.e. above the breakpoint (32 mg/L), are mandatory. The aim of this study is to evaluate the blood concentrations of cefuroxime during and after CABG surgery with cardiopulmonary bypass (CPB) and hypothermia, to determine the concentration of cefuroxime in sternum fluid and to evaluate possible factors of influence.

METHODS

Seventeen patients were enrolled in this study, given 1.5 g cefuroxime at anaesthesia induction and an additional 1.5 g at start CPB. Blood samples were collected at skin incision, start CPB, every 30 min on CPB, end CPB, at wound closure and 1 h after surgery. Cefuroxime concentrations were determined by high performance liquid chromatography.

RESULTS

In 47 % of the patients the cefuroxime concentration was below the breakpoint at some point during the operation and in 59 % of the patients 1 h after surgery. A statistically significant inverse correlation between estimated glomerular filtration rate and plasma cefuroxime concentrations was found (P = 0.034). Cefuroxime levels in the sternum are not significantly different from blood levels from the radial artery catheter, taken at approximately the same time (P = 0.30).

CONCLUSIONS

The current antibiotic regimen used did not maintain cefuroxime concentrations above the breakpoint throughout the operation, suggesting insufficient antibiotic prophylaxis. Further research to other antibiotic regimes is therefore necessary.

摘要

目的

冠状动脉旁路移植术(CABG)患者有发生严重术后感染的风险。预防性使用头孢呋辛可能有助于降低这种风险,然而,需要维持足够的浓度,即高于折点(32mg/L)。本研究旨在评估体外循环(CPB)和低温下 CABG 手术期间和之后头孢呋辛的血液浓度,确定胸骨液中的头孢呋辛浓度,并评估可能的影响因素。

方法

本研究纳入了 17 名患者,在麻醉诱导时给予 1.5g 头孢呋辛,在 CPB 开始时给予另外 1.5g。在皮肤切开时、CPB 开始时、CPB 每 30 分钟、CPB 结束时、伤口关闭时和手术后 1 小时采集血样。通过高效液相色谱法测定头孢呋辛浓度。

结果

在 47%的患者中,在手术过程中的某个时刻,头孢呋辛浓度低于折点,在 59%的患者中,在手术后 1 小时时浓度低于折点。估计肾小球滤过率与血浆头孢呋辛浓度呈显著负相关(P=0.034)。胸骨内的头孢呋辛水平与桡动脉导管内的血液水平(大约在同一时间采集)无显著差异(P=0.30)。

结论

目前使用的抗生素方案在整个手术过程中未能维持头孢呋辛浓度高于折点,提示抗生素预防不足。因此,需要进一步研究其他抗生素方案。

相似文献

1
Blood concentrations of cefuroxime in cardiopulmonary bypass surgery.体外循环手术中头孢呋辛的血药浓度。
Int J Clin Pharm. 2013 Oct;35(5):798-804. doi: 10.1007/s11096-013-9810-z. Epub 2013 Jun 21.
2
Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass.在体外循环冠状动脉搭桥手术期间靶向头孢呋辛血浆浓度。
Int J Clin Pharm. 2015 Aug;37(4):592-8. doi: 10.1007/s11096-015-0101-8. Epub 2015 Mar 20.
3
Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.体外循环对行冠状动脉手术患者头孢呋辛血药浓度及药代动力学的影响。
Eur J Cardiothorac Surg. 2012 Aug;42(2):300-5. doi: 10.1093/ejcts/ezr319. Epub 2012 Jan 26.
4
Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass.接受体外循环冠状动脉搭桥术患者预防性使用头孢呋辛的全身药物利用度。
J Hosp Infect. 2005 Apr;59(4):299-303. doi: 10.1016/j.jhin.2004.10.004.
5
Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.头孢呋辛在心脏手术婴儿和新生儿中的药代动力学。
Br J Clin Pharmacol. 2018 Sep;84(9):2020-2028. doi: 10.1111/bcp.13632. Epub 2018 Jun 15.
6
Tissue and plasma concentrations of cephuroxime during cardiac surgery in cardiopulmonary bypass--a microdialysis study.心脏手术体外循环期间头孢呋辛的组织和血浆浓度——一项微透析研究
Perfusion. 2007 Mar;22(2):129-36. doi: 10.1177/0267659107080116.
7
Tissue and plasma concentrations of antibiotic during cardiac surgery with cardiopulmonary bypass--microdialysis study.体外循环心脏手术期间抗生素的组织和血浆浓度——微透析研究
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Jun;152(1):139-45. doi: 10.5507/bp.2008.022.
8
Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels.单剂量抗生素预防对冠状动脉搭桥手术是否足够?围手术期及术后头孢呋辛和万古霉素血清水平分析。
J Hosp Infect. 1997 Nov;37(3):237-47. doi: 10.1016/s0195-6701(97)90252-8.
9
Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.基于群体药代动力学模型的体外循环下冠状动脉旁路移植术应用头孢呋辛标准给药方案的评价。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02241-17. Print 2018 Apr.
10
Population pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis during and after cardiopulmonary bypass.心脏体外循环期间和之后围手术期抗生素预防应用中头孢呋辛的群体药代动力学评价。
Br J Clin Pharmacol. 2021 Mar;87(3):1486-1498. doi: 10.1111/bcp.14556. Epub 2020 Nov 17.

引用本文的文献

1
Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery.头孢唑林预防瓣膜置换手术围手术期药代动力学。
PLoS One. 2023 Sep 20;18(9):e0291425. doi: 10.1371/journal.pone.0291425. eCollection 2023.
2
Antibiotics and ECMO in the Adult Population-Persistent Challenges and Practical Guides.成人人群中的抗生素与体外膜肺氧合——持续挑战与实用指南
Antibiotics (Basel). 2022 Mar 4;11(3):338. doi: 10.3390/antibiotics11030338.
3
Pharmacokinetic Model for Cefuroxime Dosing during Cardiac Surgery under Cardiopulmonary Bypass.

本文引用的文献

1
Clinical practice guidelines for antimicrobial prophylaxis in surgery.手术抗菌预防临床实践指南
Am J Health Syst Pharm. 2013 Feb 1;70(3):195-283. doi: 10.2146/ajhp120568.
2
Estimation of glomerular filtration rate by MDRD equation in athletes: role of body surface area.MDRD 方程估算运动员的肾小球滤过率:体表面积的作用。
Eur J Appl Physiol. 2012 Jan;112(1):201-6. doi: 10.1007/s00421-011-1969-1. Epub 2011 Apr 26.
3
Estimation of cefuroxime dosage using pharmacodynamic targets, MIC distributions, and minimization of a risk function.
心脏手术体外循环期间头孢呋辛给药的药代动力学模型。
Antimicrob Agents Chemother. 2020 Nov 17;64(12). doi: 10.1128/AAC.01687-20.
4
Quantification of total and unbound cefuroxime in plasma by ultra-performance liquid chromatography tandem mass spectrometry in a cohort of critically ill patients with hypoalbuminemia and renal failure.采用超高效液相色谱串联质谱法对低蛋白血症和肾衰竭危重症患者的血浆中总头孢呋辛和游离头孢呋辛进行定量分析。
J Clin Lab Anal. 2020 Mar;34(3):e23100. doi: 10.1002/jcla.23100. Epub 2019 Nov 30.
5
Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.头孢呋辛在心脏手术婴儿和新生儿中的药代动力学。
Br J Clin Pharmacol. 2018 Sep;84(9):2020-2028. doi: 10.1111/bcp.13632. Epub 2018 Jun 15.
6
Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.基于群体药代动力学模型的体外循环下冠状动脉旁路移植术应用头孢呋辛标准给药方案的评价。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02241-17. Print 2018 Apr.
7
Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass.在体外循环冠状动脉搭桥手术期间靶向头孢呋辛血浆浓度。
Int J Clin Pharm. 2015 Aug;37(4):592-8. doi: 10.1007/s11096-015-0101-8. Epub 2015 Mar 20.
使用药效学靶点、最低抑菌浓度分布及风险函数最小化来估算头孢呋辛剂量。
J Clin Pharmacol. 2008 Nov;48(11):1270-81. doi: 10.1177/0091270008320923.
4
Tissue and plasma concentrations of antibiotic during cardiac surgery with cardiopulmonary bypass--microdialysis study.体外循环心脏手术期间抗生素的组织和血浆浓度——微透析研究
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008 Jun;152(1):139-45. doi: 10.5507/bp.2008.022.
5
Tissue and plasma concentrations of cephuroxime during cardiac surgery in cardiopulmonary bypass--a microdialysis study.心脏手术体外循环期间头孢呋辛的组织和血浆浓度——一项微透析研究
Perfusion. 2007 Mar;22(2):129-36. doi: 10.1177/0267659107080116.
6
Perioperative cefuroxime pharmacokinetics in cardiac surgery.心脏手术中围手术期头孢呋辛的药代动力学
Clinics (Sao Paulo). 2007 Jun;62(3):257-60.
7
The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration.胸外科医师协会实践指南系列:心脏手术中的抗生素预防,第一部分:持续时间。
Ann Thorac Surg. 2006 Jan;81(1):397-404. doi: 10.1016/j.athoracsur.2005.06.034.
8
Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project.手术抗菌预防:国家外科感染预防项目的一份咨询声明
Am J Surg. 2005 Apr;189(4):395-404. doi: 10.1016/j.amjsurg.2005.01.015.
9
Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass.接受体外循环冠状动脉搭桥术患者预防性使用头孢呋辛的全身药物利用度。
J Hosp Infect. 2005 Apr;59(4):299-303. doi: 10.1016/j.jhin.2004.10.004.
10
10-year follow-up of patients with and without mediastinitis.有纵隔炎和无纵隔炎患者的10年随访
Semin Thorac Cardiovasc Surg. 2004 Spring;16(1):70-6. doi: 10.1053/j.semtcvs.2004.01.006.